News

The Itovebi-based regimen is approved for the treatment of adults with endocrine-resistant, PIK3CA -mutated, HR-positive, ...
Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blin ...
JK Brackens were undone by arch-rivals Clonmel Commercials in a hard-fought County Football League Division 1 final on Sunday evening, the extra man for the winners being the decisive factor.
A better all round Brian Borus team claimed victory over a game Kiladangan side in an exciting County Junior ‘A’ Camogie ...
The Canadian juggernaut have offered the new-look Wallaroos a harsh pre-World Cup reminder of their standing with a 45-7 Test ...
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 billion by 2030, growing at a CAGR of 8.3% according to a new report by The ...
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
TPG (NasdaqGS:TPG) recently completed a follow-on equity offering, raising $992 million, and launched TPG Sports with notable partnerships. These developments came amidst a rebound in the broader ...
AttackIQ has updated an existing assessment template in response to the CISA Advisory (AA25-141B) published on May 21, 2025, which disseminates Tactics, Techniques and Procedures (TTPs) and Indicators ...
BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...
Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 20 abstracts in multiple cancers at the 2025 American Society of Clinical Oncology Scientific ...